Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Gross Profit (2019 - 2025)

Historic Gross Profit for Silo Pharma (SILO) over the last 7 years, with Q3 2025 value amounting to -$2662.0.

  • Silo Pharma's Gross Profit fell 11606.91% to -$2662.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $47036.0, marking a year-over-year decrease of 2901.73%. This contributed to the annual value of $66264.0 for FY2024, which is 0.0% changed from last year.
  • Silo Pharma's Gross Profit amounted to -$2662.0 in Q3 2025, which was down 11606.91% from $16566.0 recorded in Q2 2025.
  • Silo Pharma's 5-year Gross Profit high stood at $16566.0 for Q2 2021, and its period low was -$2662.0 during Q3 2025.
  • Moreover, its 5-year median value for Gross Profit was $16566.0 (2021), whereas its average is $15553.8.
  • Per our database at Business Quant, Silo Pharma's Gross Profit surged by 778714.29% in 2021 and then crashed by 11606.91% in 2025.
  • Quarter analysis of 5 years shows Silo Pharma's Gross Profit stood at $16566.0 in 2021, then changed by 0.0% to $16566.0 in 2022, then changed by 0.0% to $16566.0 in 2023, then changed by 0.0% to $16566.0 in 2024, then plummeted by 116.07% to -$2662.0 in 2025.
  • Its Gross Profit was -$2662.0 in Q3 2025, compared to $16566.0 in Q2 2025 and $16566.0 in Q1 2025.